The Economic Burden of Candidemia and Invasive Candidiasis: A Systematic Review
Background: Candidemia or invasive candidiasis (IC) is an increasingly common fungal infection and has been associated with high mortality, particularly among the immunocompromised and critically ill. Although several studies have been conducted to estimate the cost of managing candidemia and IC, qu...
Main Authors: | Wan Ismail, Wan Nor Ain, Jasmi, Nadhirah, Khan, Tahir Mehmood, Hong, Yet Hoi, Neoh, Chin Fen |
---|---|
Format: | Article |
Published: |
Elsevier
2020
|
Subjects: |
Similar Items
-
Survey of knowledge, attitudes and practice regarding adverse drug reaction (ADR) reporting among community pharmacists in Selangor, Malaysia
by: Zin, Rosdi Md, et al.
Published: (2019) -
Invasive candidiasis and candidemia in pediatric and neonatal patients: A review of current guidelines
by: Eleni Vasileiou, et al.
Published: (2018-09-01) -
Cost-utility analysis of caspofungin and fluconazole for primary treatment of invasive candidiasis and candidemia in Ethiopia
by: Gebremedhin Beedemariam Gebretekle, et al.
Published: (2022-10-01) -
Cost-effectiveness of three echinocandins and fluconazole in the treatment of candidemia and/or invasive candidiasis in nonneutropenic adult patients
by: Grau S, et al.
Published: (2015-10-01) -
Necrotizing pancreatitis with invasive candidiasis and candidemia due to Candida albicans and pan-echinocandin-resistant Candida glabrata
by: Laman Rahimli, et al.
Published: (2024-03-01)